Nasdaq - Delayed Quote USD

Janus Henderson Global Life Sciences Fund Class N Shares (JFNNX)

76.06 +0.30 (+0.40%)
As of 8:05 AM EDT. Market Open.
Loading Chart for JFNNX
DELL
  • Previous Close 75.76
  • YTD Return 7.26%
  • Expense Ratio 0.98%
  • Category Health
  • Last Cap Gain 24.00
  • Morningstar Rating
  • Morningstar Risk Rating Above Average
  • Sustainability Rating
  • Net Assets 5.1B
  • Beta (5Y Monthly) 0.75
  • Yield 0.20%
  • 5y Average Return --
  • Holdings Turnover 34.00%
  • Last Dividend 0.15
  • Inception Date Dec 31, 1998

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Janus Henderson

Fund Family

Health

Fund Category

5.1B

Net Assets

1998-12-31

Inception Date

Performance Overview: JFNNX

Trailing returns as of 6/11/2024. Category is Health.

YTD Return

JFNNX
7.26%
Category
7.95%
 

1-Year Return

JFNNX
15.03%
Category
30.16%
 

3-Year Return

JFNNX
6.12%
Category
16.10%
 

5-Year Return

JFNNX
12.77%
Category
15.71%
 

People Also Watch

Holdings: JFNNX

Top 10 Holdings (38.01% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 7.06%
UNH
UnitedHealth Group Incorporated 5.85%
NOVO-B.CO
Novo Nordisk A/S 5.18%
MRK
Merck & Co., Inc. 3.63%
AZN.L
AstraZeneca PLC 3.57%
ABBV
AbbVie Inc. 3.36%
SAN.PA
Sanofi 2.49%
BSX
Boston Scientific Corporation 2.31%
VRTX
Vertex Pharmaceuticals Incorporated 2.30%
ABT
Abbott Laboratories 2.27%

Sector Weightings

SectorJFNNX
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: JFNNX

Research Reports: JFNNX

Top Mutual Funds